Mississippi

Overview

Mississippi voters approved a medical-cannabis ballot initiative (Initiative 65) in November 2020 with 74% support, but the Mississippi Supreme Court invalidated the initiative on May 14, 2021 in In re Initiative Measure No. 65 v. Watson, citing an unconstitutional flaw in the state's initiative process. The legislature responded with Senate Bill 2095 (the Mississippi Medical Cannabis Act) signed by Governor Tate Reeves on February 2, 2022 and codified at Miss. Code Ann. §41-137-1 et seq. Licensed medical sales began January 25, 2023.

Recreational cannabis remains illegal. Possession of up to 30 grams was previously a civil violation with a $100–$250 fine under Mississippi's longstanding decriminalization (Miss. Code §41-29-139); SB 2095 did not alter recreational penalties.

The Mississippi State Department of Health (MSDH) administers patient registration and dispensary licensing; the Department of Revenue handles taxation.

Medical program (Medical Cannabis Act, 2022)

Qualifying conditions

The Mississippi medical program enumerates a substantial qualifying-condition list:

• Cancer, glaucoma, HIV/AIDS
• ALS, multiple sclerosis, Parkinson's disease, Alzheimer's disease, Huntington's disease
• Crohn's disease
• Severe and chronic pain, severe nausea
• Cachexia / wasting
• Seizure disorders, epilepsy
• Post-traumatic stress disorder
• Sickle cell disease
• Autism spectrum disorder
• Terminal illness (life expectancy under 12 months)
• Any other chronic, terminal, or debilitating disease or medical condition producing one of the enumerated symptoms

Patient access

• Possession: the statute uses a Mississippi Medical Cannabis Equivalency Unit (MMCEU) system; up to 3.5 grams cannabis-equivalent per day, capped at 24 MMCEU (approximately 3 ounces) per 30-day period.
• Home cultivation: prohibited.
• Reciprocity: none. Patients must be Mississippi residents to register.
• Approved forms: flower (since later rulemaking), edibles, oils, tinctures, capsules, vapes, topicals.

Recreational penalties

First-offense possession of 30 grams or less is a civil violation with a $100–$250 fine. Possession over 30 grams scales to misdemeanor or felony under Miss. Code §41-29-139, with penalties scaling by quantity.

Patients and caregivers

• Patient minimum age: 18. Minor patients require parent/legal guardian as designated caregiver plus physician certification (and a second-physician concurrence requirement in some condition categories).
• Caregiver minimum age: 21.
• Caregivers per patient: up to 1 designated caregiver per patient.
• Caregiver registration: via MSDH; criminal background check.

Patient registration steps

1. Schedule a visit with a Mississippi-licensed practitioner registered with the MSDH Medical Cannabis Program. Qualifying practitioners include physicians, nurse practitioners, physician assistants, and optometrists (for glaucoma certification).
2. The practitioner confirms a qualifying condition through an in-person evaluation and submits the written certification through the MSDH portal. Certain conditions (including chronic pain) require certification by a physician (not a mid-level practitioner).
3. The patient applies through the MSDH Medical Cannabis Program portal, submits identity documents, proof of Mississippi residency, and a current photo. The standard registration fee is $25; the annual renewal fee is $25.
4. Approved patients receive a state-issued ID card valid for one year and renewable. The card authorizes purchases at any licensed Mississippi dispensary.

Minor patients require a parent or legal guardian as designated caregiver and a second physician's concurring certification. The caregiver completes a separate application and background check.

Reciprocity and visiting patients

Mississippi does not extend reciprocity to any out-of-state medical-cannabis program. Patients must be Mississippi residents to register. Visiting patients carrying medical cards from Louisiana, Alabama, Tennessee, or Arkansas cannot purchase from Mississippi dispensaries and remain subject to state criminal penalties for cannabis brought across the border.

The longstanding decriminalization framework for first-offense possession of 30 grams or less provides some practical protection for visitors carrying small amounts. It does not eliminate civil-fine exposure or criminal-record risk for any amount above the threshold or any sale or distribution activity.

Employment and workplace

Mississippi is an at-will employment state. The Medical Cannabis Act includes limited patient-protection language but preserves broad employer discretion:

• Safety-sensitive positions: employers may continue to enforce drug-free workplace policies for safety-sensitive roles as defined by the employer.
• Federal contractor and DOT-regulated positions: federal drug-free workplace and DOT testing rules supersede state-level patient protection.
• Workers' compensation: post-incident testing positive for THC may result in benefit denial unless the patient documents medical use within certified parameters at the time of the incident.

The Act explicitly preserves employer authority to prohibit on-the-job impairment and to maintain drug-free workplace policies for safety-sensitive positions. Public-employee positions, healthcare licensing, and CDL holders face additional licensing-board exposure beyond employer discipline.

Hemp-derived intoxicants

Mississippi has taken a relatively restrictive posture on hemp-derived intoxicating cannabinoids. The 2023 session considered restrictions on delta-8 THC, delta-10 THC, THC-O, and HHC products. Enforcement varies by jurisdiction; retail availability has been substantial through gas-station, vape-shop, and dedicated hemp-retailer channels. The Mississippi State Department of Health has issued advisories noting that hemp-derived intoxicating products are not regulated under the Medical Cannabis Act and are not part of the licensed dispensary supply chain.

Recent legislative history

Notable developments since the 2022 Act:

• 2022: SB 2095 (Medical Cannabis Act) enacted following Initiative 65 invalidation.
• 2023: licensed sales began January 25; MSDH rulemaking adjusted possession-cap calculations and product-form authorizations (including raw flower).
• 2024: legislative review focused on dispensary licensing, caregiver eligibility, and chronic-pain certification criteria.
• 2025-2026: ongoing legislative work on local opt-out provisions (Mississippi cities and counties may opt out of dispensary licensing within their jurisdiction by ordinance), dispensary advertising, and county-level zoning.

The April 2026 federal Schedule III rescheduling order produced no immediate Mississippi legislative response.

Federal context

Federal jurisdiction layers additional exposure on federal land, federal courthouses, military installations (Keesler Air Force Base, Columbus Air Force Base, Naval Construction Battalion Center Gulfport, NAS Meridian), and interstate highways. The Natchez Trace Parkway, Gulf Islands National Seashore, and DeSoto National Forest fall under federal cannabis prohibition regardless of state authorization. I-10, I-20, I-55, and I-59 corridors see active state-patrol and federal drug-interdiction activity, particularly at the Louisiana, Alabama, and Tennessee borders.